| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Peeters TL | |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythromycin | Q213511 |
| P304 | page(s) | 1886-1899 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Erythromycin and other macrolides as prokinetic agents | |
| P478 | volume | 105 |
| Q28082238 | Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review |
| Q35353756 | Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin |
| Q35202119 | Anesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative Ileus |
| Q94400760 | Antibiotic prophylaxis for people with cirrhosis and variceal bleeding |
| Q49044509 | Central, but not peripheral application of motilin increases c-Fos expression in hypothalamic nuclei in the rat brain |
| Q34981230 | Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. |
| Q40498391 | Delayed Gastric Emptying in Functional Dyspepsia |
| Q79890368 | Delayed gastric emptying: whom to test, how to test, and what to do |
| Q36319022 | Diabetes mellitus and the nervous system |
| Q40737151 | Diabetic and Nondiabetic Gastroparesis |
| Q46895232 | Direct inhibitory effect of erythromycin on the gallbladder muscle. |
| Q42048821 | Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers |
| Q42730054 | Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats |
| Q57011531 | Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis |
| Q28346269 | Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial |
| Q80152563 | Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro |
| Q46952496 | Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys |
| Q34611294 | Equine gastrointestinal motility--ileus and pharmacological modification |
| Q35296967 | Erythromycin as a prokinetic agent in preterm neonates: a systematic review |
| Q41333073 | Expression of motilin in the hypothalamus and the effect of central erythromycin on gastric motility in diabetic rats |
| Q33571822 | Formulary management of macrolide antibiotics |
| Q34026147 | Gastroesophageal reflux and altered motility in lung transplant rejection. |
| Q54545068 | Giant gastric ulcers and risk factors for gastroduodenal mucosal disease in orthotopic lung transplant patients. |
| Q37722509 | Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin. |
| Q43087399 | Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans |
| Q37885246 | Macrolide antibiotics in paediatric infectious diseases |
| Q72894485 | Motilin receptor: a model for development of prokinetics |
| Q35100294 | New developments in the treatment of functional dyspepsia |
| Q40504527 | Pharmacokinetic considerations in gastrointestinal motor disorders |
| Q33717384 | Principles of applied neurogastroenterology: physiology/motility-sensation. |
| Q35669824 | Progress with novel pharmacological strategies for gastro-oesophageal reflux disease. |
| Q34967021 | The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? |
| Q41903191 | The effect of erythromycin on gastrointestinal motility in subtotal gastrectomized patients |
| Q35215647 | The hungry stomach: physiology, disease, and drug development opportunities. |
| Q36903406 | The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying |
| Q55533590 | Treatment Challenges in the Management of Gastroparesis-Related GERD. |
| Q84568726 | [Perioperative protection of the gastrointestinal tract] |
Search more.